HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 42,133 Value ($000) $2,689 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 40,948 Value ($000) $1,958 Avg Close $51.28 Range $42.01 - $62.13
Q2 2024
Shares 37,082 Value ($000) $1,942 Avg Close $43.86 Range $37.73 - $53.00
Q4 2023
Shares 159,242 Value ($000) $5,886 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 173,108 Value ($000) $6,613 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 110,480 Value ($000) $3,985 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 133,208 Value ($000) $5,087 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 105,539 Value ($000) $6,005 Avg Close $51.20 Range $39.17 - $59.46
Q2 2022
Shares 37,513 Value ($000) $1,651 Avg Close $43.25 Range $36.95 - $48.58
Q4 2020
Shares 5,332 Value ($000) $228 Avg Close $35.95 Range $25.70 - $44.53
Q2 2017
Shares 11,625 Value ($000) $149 Avg Close $13.36 Range $11.51 - $15.05
Q1 2014
Shares 20,110 Value ($000) $282 Avg Close $14.84 Range $11.28 - $18.18